GUEST COMMENTARY—For millions of patients, the slow pace of drug discovery means years – sometimes decades – without effective treatments. Many diseases remain untreatable, not because they ...

Drug screening is the process by which potential drugs are identified and optimized before selection of a candidate drug to progress to clinical trials. It can involve screening large libraries of ...

“They are not doctors, but they work with insurance companies to deny people the drugs and treatments doctors prescribe,” Pritzker said. “Not only are they driving up health care costs for ...

April 22 (Reuters) - AstraZeneca (AZN.L), opens new tab has rejoined the main U.S. drug lobby group, roughly two years after leaving it, the Pharmaceutical Research and Manufacturers of America ...

Drug therapy (or pharmacotherapy) involves the administration of drugs to treat or prevent disease. In some cases – often in the treatment of disease such as cancer, HIV infection and diabetes ...

Consisting of five separate booklets, the World Drug Report 2021 provides an in-depth analysis of the global drug markets and paints a comprehensive picture of the measurable effects and potential ...

the company said in a statement Tuesday. The trial would have supported a broader approval for the drug.

SPRINGFIELD, Mo. (KY3) - The Drug Enforcement Administration encourages everyone to turn in their unused and unwanted prescriptions on Saturday, April 26, during National Prescription Drug Take ...

Ozempic (semaglutide) and metformin are prescription drugs that are both used to help manage blood sugar levels in people with type 2 diabetes. Ozempic is a brand-name drug, while metformin is a ...

When a medication works right, it boosts your health or helps you feel better. But a drug can bring on problems if it doesn't mix well with something else you put into your body, like another ...

GATHER2 showed that some patients could get a benefit from the drug with dosing every other month, and also that there were benefits to continuing treatment out to two years. Complement C3 ...

Bristol-Myers Squibb's $14 billion bet on buying Karuna Therapeutics looks set to pay off after it got FDA approval for the schizophrenia drug at the heart of the deal. The US regulator has ...